John W.M. Claud

Commissioner Makary Charts A New Course For FDA At FDLI Annual Conference

Knock Knock. Who's There? (Or Quién Es? Or Qui Est-ce? Or Wer Ist Es?) Surprise, It's FDA!

Reports Document FDA Review Delays: What Drugmakers Should Know Now

While FDA Suffers Staffing Cuts, Nondelegation Case In SCOTUS Is Latest Legal Challenge To Curb Agency Powers

In Uncertain Times, Good Compliance And Quality Communication Habits Can Offer A Port In The Storm

FOIA Requires Transparency Of Instructions To FDA Staff, Even When Those Instructions Are To Pause Communications With The Public

What We're Watching For In The Senate Confirmation Hearings To Consider Robert F. Kennedy, Jr. To Be Secretary Of HHS

GAO Report Recommends Retaining FDA's Drug Inspectional Workforce As Agency Prepares For Trumpian Changes

From The Porcine To The Ridiculous To The Court Of Appeals: Phibro's Suit Against FDA Gets Muddy

As Jurisprudence Under Loper Bright Develops, Early Scorecard Is Mixed